These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 12123856)

  • 1. Heterogeneity of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide receptors in rat intrinsic cardiac neurons.
    DeHaven WI; Cuevas J
    Neurosci Lett; 2002 Aug; 328(1):45-9. PubMed ID: 12123856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of VPAC2 receptor and PAC1 receptor splice variants in the trigeminal ganglion of the adult rat.
    Chaudhary P; Baumann TK
    Brain Res Mol Brain Res; 2002 Aug; 104(2):137-42. PubMed ID: 12225867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary adenylate cyclase-activating polypeptide expression and modulation of neuronal excitability in guinea pig cardiac ganglia.
    Braas KM; May V; Harakall SA; Hardwick JC; Parsons RL
    J Neurosci; 1998 Dec; 18(23):9766-79. PubMed ID: 9822736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of PAC1 receptor isoform mRNAs by real-time PCR in rat suprachiasmatic nucleus.
    Ajpru S; McArthur AJ; Piggins HD; Sugden D
    Brain Res Mol Brain Res; 2002 Sep; 105(1-2):29-37. PubMed ID: 12399105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
    Basille M; Vaudry D; Coulouarn Y; Jegou S; Lihrmann I; Fournier A; Vaudry H; Gonzalez B
    J Comp Neurol; 2000 Oct; 425(4):495-509. PubMed ID: 10975876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes.
    Grimaldi M; Cavallaro S
    Eur J Neurosci; 1999 Aug; 11(8):2767-72. PubMed ID: 10457173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
    Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
    Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.
    Joo KM; Chung YH; Kim MK; Nam RH; Lee BL; Lee KH; Cha CI
    J Comp Neurol; 2004 Aug; 476(4):388-413. PubMed ID: 15282712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
    Drahushuk K; Connell TD; Higgins D
    J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons.
    Tatsuno I; Uchida D; Tanaka T; Saeki N; Hirai A; Saito Y; Moro O; Tajima M
    Brain Res; 2001 Jan; 889(1-2):138-48. PubMed ID: 11166697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor.
    Sano H; Miyata A; Horio T; Nishikimi T; Matsuo H; Kangawa K
    Regul Pept; 2002 Nov; 109(1-3):107-13. PubMed ID: 12409222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system].
    Hashimoto H
    Yakugaku Zasshi; 2002 Dec; 122(12):1109-21. PubMed ID: 12510388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional properties of the pituitary adenylate cyclase activating peptide (PAC1) receptor in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Busto R; Sánchez-Chapado M; Guijarro LG; Prieto JC
    Cell Signal; 1999 Nov; 11(11):813-9. PubMed ID: 10617284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of intestinal receptors for VIP and PACAP in rat and in PAC1 receptor knockout mouse.
    Ekblad E; Jongsma H; Brabet P; Bockaert J; Sundler F
    Ann N Y Acad Sci; 2000; 921():137-47. PubMed ID: 11193817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.